Search
LB Pharmaceuticals Inc
LBRXAdd to Watchlist
43.010USD
+0.550+1.30%
Close 11-13 16:00（ET）
1.39BMarket Cap
LossP/E TTM
LBRX Analyst Recommendation Trends
In the current month, LBRX has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LBRX average Analyst price target in the last month is 58.917.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
3
2
2
2
2
2
6
6
6
5
4
4
2
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
9
9
7
6
6
4
4
Financial Forecasting
Based on analysts' estimates, LBRX EPS is projected to reach -1.846 in FY2026Q4, following reported EPS of -1.786 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.74
-0.80
-1.62
-1.85
-1.81
Actual
-0.67
-1.71
-1.79
--
--
Surprise
+9.44%
-113.14%
-10.16%
--
--
FAQs
How have LB Pharmaceuticals IncLBRX's recent earnings per share performed?
The market expectation was USD -1.79, while LB Pharmaceuticals IncLBRX's earnings per share (EPS) for the previous quarter was USD -1.71. EPS for the next quarter is expected at USD -1.85.
What is the analyst rating for LB Pharmaceuticals Inc?
Based on the ratings of LB Pharmaceuticals Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.